Bertrand Routy

22PUBLICATIONS
127CO-AUTHORS
Tumour immunologyMolecular targetsEnvironmental epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 08, 2026
Diet-microbiome synergy underlies obesity-associated immunotherapy efficacy.

|Jun 25, 2026
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

|Feb 11, 2026
Gut microbiome of patients with nonatopic chronic hand eczema (CHE) is distinct and enriched in immunomodulatory bacteria species compared with patients with atopic CHE and healthy individuals.

Robert Bissonnette, Youssef Salem, Ana Palijan

|Jan 28, 2026
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.

Sreya Duttagupta, Meriem Messaoudene, Sebastian Hunter

|Dec 10, 2025
Antibiotic-related dysbiosis in cancer immunotherapy: from preclinical insights to practice-changing evidence.

Bertrand Routy, Edmond Rafie, Arielle Elkrief

|Nov 21, 2025
Cancer cell-derived IL-1β reverses chemo-immunotherapy resistance in non-small cell lung cancer.

Anaïs Perrichet, Julie Lecuelle, Emeric Limagne

Pageof 4

Frequent Collaborators

7 joint publications

Laurence Zitvogel

6 joint publications

Guido Kroemer

6 joint publications

Marine Fidelle

6 joint publications

Lisa Derosa